Skip to main content

News

By Adam Ang | 03:35 am | August 17, 2022
There is a plan to expand its trial to more ambulances in the country to study its effectiveness.
By Adam Ang | 03:30 am | August 17, 2022
It features more than 1,200 combinations of randomised simulated situations in a hospital ward.
By Adam Ang | 03:19 am | August 17, 2022
The company also has pending approvals for the device in Australia and Thailand.
By Emily Olsen | 02:11 pm | August 16, 2022
The layoffs represent 13% of the AI-backed genomic and clinical data company's workforce.
By Emily Olsen | 12:46 pm | August 16, 2022
The Visibly Digital Acuity Product uses a touchscreen mobile device paired with a computer to test how sharp a user's vision is at a distance.
By Adam Ang | 04:26 am | August 16, 2022
The online treatment has been licensed to Blue Note Therapeutics for the development of a counterpart version in North America.
By Emily Olsen | 02:43 pm | August 15, 2022
A memo sent to employees from CEO David Ko said the company is "not immune to the impacts of the current economic environment."
By Emily Olsen | 12:40 pm | August 15, 2022
The virtual reality startup said the investment brings its total raise to more than $30 million.
By Emily Olsen | 10:52 am | August 12, 2022
A live website about the offerings also details a partnership with digital mental health company Ginger.
By Adam Ang | 01:30 am | August 12, 2022
Also, engineers from the University of Hong Kong have come up with a tiny biosensing platform for personalised health monitoring.